Back to Search
Start Over
[Molecular pharmacogenetic study on antipsychotic-drug therapy responders with depression or schizophrenia].
- Source :
-
Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica [Seishin Shinkeigaku Zasshi] 2006; Vol. 108 (6), pp. 633-41. - Publication Year :
- 2006
- Subjects :
- Adult
Alleles
Antidepressive Agents, Second-Generation adverse effects
Antidepressive Agents, Second-Generation pharmacokinetics
Antipsychotic Agents adverse effects
Antipsychotic Agents pharmacokinetics
Benzodiazepines adverse effects
Benzodiazepines pharmacokinetics
Benzodiazepines therapeutic use
Cytochrome P-450 CYP2D6 genetics
Female
Fluvoxamine adverse effects
Fluvoxamine pharmacokinetics
Humans
Male
Olanzapine
Polymorphism, Genetic
Prolactin blood
Receptor, Serotonin, 5-HT1A genetics
Receptor, Serotonin, 5-HT2A genetics
Antidepressive Agents, Second-Generation therapeutic use
Antipsychotic Agents therapeutic use
Depression drug therapy
Depression genetics
Fluvoxamine therapeutic use
Pharmacogenetics
Schizophrenia drug therapy
Schizophrenia genetics
Subjects
Details
- Language :
- Japanese
- ISSN :
- 0033-2658
- Volume :
- 108
- Issue :
- 6
- Database :
- MEDLINE
- Journal :
- Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica
- Publication Type :
- Academic Journal
- Accession number :
- 16910543